These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
44. Emergence of VIM-4- and SHV-12-producing Enterobacter cloacae in a neonatal intensive care unit. Juhász E; Jánvári L; Tóth A; Damjanova I; Nobilis A; Kristóf K Int J Med Microbiol; 2012 Nov; 302(6):257-60. PubMed ID: 22721811 [TBL] [Abstract][Full Text] [Related]
45. Ascorbate as an induction inhibitor of beta-lactamase in a strain of Enterobacter cloacae. Shoeb HA; Al-Shora HI; Abdel-Salam T Lett Appl Microbiol; 1995 Dec; 21(6):398-401. PubMed ID: 8554767 [TBL] [Abstract][Full Text] [Related]
46. Genomic and Geographic Context for the Evolution of High-Risk Carbapenem-Resistant Gomez-Simmonds A; Annavajhala MK; Wang Z; Macesic N; Hu Y; Giddins MJ; O'Malley A; Toussaint NC; Whittier S; Torres VJ; Uhlemann AC mBio; 2018 May; 9(3):. PubMed ID: 29844109 [TBL] [Abstract][Full Text] [Related]
47. A Snapshot of Co-Resistance to Carbapenems and Tigecycline in Clinical Isolates of Enterobacter cloacae. Huang LF; Lee CT; Su LH; Chang CL Microb Drug Resist; 2017 Jan; 23(1):1-7. PubMed ID: 27136494 [TBL] [Abstract][Full Text] [Related]
48. The cyclohexane tolerance and Phe-Arg-β-naphtylamide susceptibility of multidrug-resistant Enterobacter cloacae clinical isolates, and the predominance of one PFGE clone in Hungary. Glatz K; Tóth A; Pászti J Clin Microbiol Infect; 2011 Aug; 17(8):1254-61. PubMed ID: 21029248 [TBL] [Abstract][Full Text] [Related]
49. Discordance in the minimal inhibitory concentrations of ertapenem for Enterobacter cloacae: Vitek 2 system versus Etest and agar dilution methods. Pailhoriès H; Cassisa V; Lamoureux C; Chesnay A; Lebreton C; Lemarié C; Kempf M; Mahaza C; Joly-Guillou ML; Eveillard M Int J Infect Dis; 2014 Jan; 18():94-6. PubMed ID: 24183718 [TBL] [Abstract][Full Text] [Related]
50. [Characteristics of selected virulence factors of Enterobacter cloacae strains isolated from clinical specimens]. Nieradko J; Kurlenda J Med Dosw Mikrobiol; 2004; 56(4):351-8. PubMed ID: 15959991 [TBL] [Abstract][Full Text] [Related]
51. Probable Interspecies Transfer of the bla(VIM-4) Gene between Enterobacter cloacae and Klebsiella pneumoniae in a Single Infant Patient. Piekarska K; Zacharczuk K; Rzeczkowska M; Wołkowicz T; Januszkiewicz A; Podsiadły E; Demkow U; Gierczyński R Pol J Microbiol; 2015; 64(4):387-9. PubMed ID: 26999960 [TBL] [Abstract][Full Text] [Related]
52. Draft genome sequence of an aminoglycoside-resistant RmtD2-producing Enterobacter cloacae subsp. cloacae ST395 in Brazil. Martins ER; Casella T; Bueno MFC; Francisco GR; Tolentino FM; de Freitas ACT; Cerdeira L; Costa MN; Cevada C; Lincopan N; Garcia DO; Nogueira MCL J Glob Antimicrob Resist; 2017 Sep; 10():308-309. PubMed ID: 28757348 [TBL] [Abstract][Full Text] [Related]
53. Dynamics of colistin and tobramycin resistance among Dautzenberg MJD; Bayjanov JR; Leverstein-van Hall MA; Muller AE; Gelinck LBS; Jansen CL; Leyten EMS; Ruys T; Scharringa J; van der Starre RE; Fluit AC; Bonten MJM Antimicrob Resist Infect Control; 2018; 7():67. PubMed ID: 29796252 [TBL] [Abstract][Full Text] [Related]
54. Decreased quinolone susceptibility in high percentage of Enterobacter cloacae clinical isolates caused only by Qnr determinants. Zhao X; Xu X; Zhu D; Ye X; Wang M Diagn Microbiol Infect Dis; 2010 May; 67(1):110-3. PubMed ID: 20227223 [TBL] [Abstract][Full Text] [Related]
55. Emergence of SHV-12 extended spectrum beta-lactamase among clinical isolates of Enterobacter cloacae in Tunisia. Lahlaoui H; Anis BH; Mohamed K; Mohamed BM Microb Pathog; 2012 Aug; 53(2):64-5. PubMed ID: 22543154 [TBL] [Abstract][Full Text] [Related]
56. The use of the PhP-KE biochemical fingerprinting system in epidemiological studies of faecal Enterobacter cloacae strains from infants in Swedish neonatal wards. Kühn I; Tullus K; Burman LG Epidemiol Infect; 1991 Oct; 107(2):311-9. PubMed ID: 1936153 [TBL] [Abstract][Full Text] [Related]
57. Draft genome sequence of Enterobacter cloacae HBY, a ST128 clinical strain co-producing KPC-2 and NDM-1 carbapenemases. Li X; Zhu Y; Shen M; Du J; Zhang L; Wang D J Glob Antimicrob Resist; 2018 Mar; 12():1-2. PubMed ID: 29122729 [TBL] [Abstract][Full Text] [Related]
58. Molecular mechanisms of carbapenem resistance in Enterobacter cloacae clinical isolates from Korea and clinical outcome. Lee Y; Choi H; Yum JH; Kang G; Bae IK; Jeong SH; Lee K Ann Clin Lab Sci; 2012; 42(3):281-6. PubMed ID: 22964616 [TBL] [Abstract][Full Text] [Related]
59. Multiclonal spread of VIM-1-producing Enterobacter cloacae isolates associated with In624 and In488 integrons located in an IncHI2 plasmid. Villa J; Viedma E; Brañas P; Orellana MA; Otero JR; Chaves F Int J Antimicrob Agents; 2014 May; 43(5):451-5. PubMed ID: 24702943 [TBL] [Abstract][Full Text] [Related]
60. First report of the isolation of bla Tarumoto N; Kodana M; Watanabe N; Sakai J; Imai K; Yamaguchi T; Taji Y; Ebihara Y; Murakami T; Maeda T; Mitsutake K; Maesaki S J Infect Chemother; 2018 Nov; 24(11):941-943. PubMed ID: 29716812 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]